Endothelins and Cardiovascular Disease: Proceedings of a satellite symposium to the 17th Scientific Meeting of the International Society of Hypertension, Padua, Italy, June 12-13, 1998ROSSI, Gian Paolo; LüSCHER, Thomas F; PESSINA, Achille C et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, 86 p.Conference Proceedings

Endothelial cell-specific regulation of the murine endothelin-1 geneFADEL, Bahaa Michel; BOUTET, Stephane C; QUERTERMOUS, Thomas et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S7-S11Conference Paper

Plasma endothelin levels : a meaningless number?MORGANTI, Alberto; MARANA, Ivana; AIROLDI, Flavio et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S21-S23Conference Paper

Endothelin : Role in experimental hypertensionSCHIFFRIN, Ernesto L.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S33-S35Conference Paper

Endothelin and endothelin receptor antagonism in heart failureSÜTSCH, Gabor; KIOWSKI, Wolfgang.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S69-S73Conference Paper

The endothelin family : An overviewMASAKI, Tomoh.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S3-S5Conference Paper

Endothelin receptor antagonists : Current status and perspectivesCLOZEL, Martine.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S65-S68Conference Paper

Abnormalities of endothelial function in the pathogenesis of stroke : The importance of endothelinVOLPE, Massimo; COSENTINO, Francesco.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S45-S48Conference Paper

Endothelin antagonists and renal protectionBENIGNI, Ariela; PERICO, Norberto; REMUZZI, Giuseppe et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S75-S78Conference Paper

Endothelin in atherosclerosis : Importance of risk factors and therapeutic implicationsD'USCIO, Livius V; BARTON, Matthias; SHAW, Sidney et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S55-S59Conference Paper

Endothelin and pulmonary hypertensionCHEN, Yiu-Fai; OPARIL, Suzanne.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S49-S53Conference Paper

Transgenic models for the study of endothelin function in the cardiovascular systemZOLLMANN, Frank S; PAUL, Martin.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S13-S16Conference Paper

Endothelin-1 and the adrenal glandROSSI, Gian Paolo; BELLONI, Anna S; NUSSDORFER, Gastone G et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S17-S20Conference Paper

Endothelin-converting enzyme inhibitors : Current status and perspectivesLÖFFLER, Bernd-Michael.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S79-S82Conference Paper

Plasma endothelin concentrations in hypertensionGODDARD, Jane; WEBB, David J.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S25-S31Conference Paper

Endothelin in cardiovascular disease : From atherosclerosis to heart failureBEST, Patricia J. M; LERMAN, Amir.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S61-S63Conference Paper

Association between diastolic blood pressure and variants of the endothelin-1 and endothelin-2 genesBROWN, Morris J; SHARMA, Pankaj; STEVENS, Patricia A et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S41-S43Conference Paper

Vascular effects of endothelin-1 in essential hypertension : Relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxideTADDEI, Stefano; VIRDIS, Agostino; GHIADONI, Lorenzo et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S37-S40Conference Paper